vTv Therapeutics
VTVT
37 hedge funds and large institutions have $32.7M invested in vTv Therapeutics in 2015 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$8.3M |
| 2 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
+$6.75M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$3.93M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.18M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$3.11M |
Top Sellers
VTVT Hedge Fund Activity: Q3 2015 in Review
37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2015, worth a combined $32.7M.
Buyers outnumbered sellers: 37 funds opened new VTVT positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $8.3M.
- 37 institutional investors held vTv Therapeutics (VTVT) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $32.7M of vTv Therapeutics stock for Q3 2015.
- 37 funds opened new vTv Therapeutics positions in Q3 2015 and 0 closed out, a net change of +37 holders.
- The largest vTv Therapeutics buyer in Q3 2015 was Franklin Resources, an estimated $8.3M added.
Based on aggregated 13F filings for Q3 2015.